MAZZAGLIA, GIAMPIERO
 Distribuzione geografica
Continente #
NA - Nord America 20.494
AS - Asia 16.135
EU - Europa 10.287
SA - Sud America 2.592
AF - Africa 334
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 13
Totale 49.879
Nazione #
US - Stati Uniti d'America 18.413
SG - Singapore 5.755
IT - Italia 3.359
VN - Vietnam 2.927
HK - Hong Kong 2.821
CN - Cina 2.522
BR - Brasile 2.041
RU - Federazione Russa 1.915
CA - Canada 1.868
IE - Irlanda 1.331
SE - Svezia 851
DE - Germania 791
FR - Francia 493
UA - Ucraina 453
GB - Regno Unito 436
BD - Bangladesh 430
IN - India 322
KR - Corea 262
AR - Argentina 239
ID - Indonesia 195
FI - Finlandia 181
IQ - Iraq 139
TR - Turchia 117
MX - Messico 104
ZA - Sudafrica 104
NL - Olanda 101
PK - Pakistan 89
EC - Ecuador 82
SA - Arabia Saudita 81
PH - Filippine 76
JP - Giappone 63
AT - Austria 60
CO - Colombia 55
PL - Polonia 52
ES - Italia 51
UZ - Uzbekistan 49
MA - Marocco 43
VE - Venezuela 43
EG - Egitto 41
MY - Malesia 41
CH - Svizzera 37
CL - Cile 37
PY - Paraguay 37
BE - Belgio 35
KE - Kenya 27
NP - Nepal 27
JO - Giordania 26
TN - Tunisia 25
AU - Australia 23
UY - Uruguay 22
PE - Perù 20
LB - Libano 19
AE - Emirati Arabi Uniti 18
CZ - Repubblica Ceca 18
JM - Giamaica 18
TH - Thailandia 18
CR - Costa Rica 17
DO - Repubblica Dominicana 17
IL - Israele 17
AL - Albania 16
DZ - Algeria 15
ET - Etiopia 15
IR - Iran 15
RO - Romania 15
KZ - Kazakistan 14
OM - Oman 14
DK - Danimarca 13
AZ - Azerbaigian 12
BO - Bolivia 11
LT - Lituania 11
PT - Portogallo 11
GT - Guatemala 10
NG - Nigeria 10
TW - Taiwan 10
NI - Nicaragua 9
PA - Panama 9
TT - Trinidad e Tobago 9
EU - Europa 8
HN - Honduras 8
MU - Mauritius 8
PS - Palestinian Territory 8
BH - Bahrain 7
LY - Libia 7
GR - Grecia 6
HU - Ungheria 6
KG - Kirghizistan 6
MD - Moldavia 6
NO - Norvegia 6
AO - Angola 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
GY - Guiana 5
KW - Kuwait 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BW - Botswana 4
PR - Porto Rico 4
QA - Qatar 4
Totale 49.804
Città #
Hong Kong 2.791
Singapore 2.615
Fairfield 1.717
Toronto 1.711
Ashburn 1.471
Ann Arbor 1.324
Dublin 1.288
Houston 1.235
Milan 917
San Jose 887
Woodbridge 887
Ho Chi Minh City 861
Santa Clara 680
Seattle 667
Wilmington 659
Hanoi 646
New York 641
Dearborn 639
Princeton 575
Cambridge 548
Chandler 493
Frankfurt am Main 479
Chicago 433
The Dalles 388
Jacksonville 370
Rome 344
Dallas 290
Lauterbourg 285
Moscow 282
Beijing 277
Los Angeles 249
Nanjing 244
Seoul 240
Altamura 221
Lawrence 201
Dong Ket 191
São Paulo 170
Hefei 166
Helsinki 127
Buffalo 117
Andover 108
Council Bluffs 100
San Diego 100
Haiphong 93
Boardman 92
Da Nang 88
Jakarta 87
London 76
Rio de Janeiro 74
Shanghai 73
Guangzhou 70
Munich 62
Nuremberg 61
Changsha 59
Turin 59
Baghdad 55
Ha Long 54
Orem 54
Shenyang 54
Nanchang 53
Hebei 52
Bologna 51
Tianjin 49
Tokyo 49
Biên Hòa 48
Ninh Bình 48
Curitiba 46
Ottawa 45
Jinan 42
Figino 41
Jiaxing 41
Salt Lake City 41
Brooklyn 40
Can Tho 40
Naples 40
Florence 39
Johannesburg 39
Hải Dương 38
Quận Bình Thạnh 37
Tashkent 37
Columbus 36
Thái Nguyên 34
Jeddah 33
Mexico City 33
Verona 33
Palermo 32
Brasília 31
Falls Church 31
Lahore 30
Belo Horizonte 29
Mumbai 29
Perugia 29
Quito 29
Dhaka 28
Phoenix 28
Porto Alegre 28
Zhengzhou 28
Chennai 27
Montreal 27
Philadelphia 27
Totale 31.263
Nome #
Triage and Evaluation of Potential Safety Signals Identified from Electronic Healthcare Record Databases 705
Intervention studies in drug utilisation research 563
Epidemiology of SLE in Italy: an observational study using a primary care database 554
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project 547
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings from 2010 to 2019 539
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 480
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 397
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 381
Valutazione del controllo della malattia da reflusso gastroesofageo in Medicina Generale attraverso l’utilizzo del questionario “GERD Impact scale” 377
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 374
Use of computerised general practice database for epidemiological studies in italy: a comparative study with the official national statistics 367
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 357
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 350
User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures 282
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 281
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 279
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 277
Discontinuity and failures of therapy with bisphosphonates: Joint assessment of predictors with multi-state models 276
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 266
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 255
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection 254
Risk of severe upper gastrointestinal complications among oral bisphosphonate users 253
The role of electronic healthcare record databases in paediatric drug safety surveillance: A retrospective cohort study 251
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 250
Harmonisation of Outcome Estraction for Hearth Failure across Data Sources in the SAFEGUARD Project 245
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 244
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 241
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 237
Azithromycin use and covid-19: a real-world observational study. 236
Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study 230
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 230
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 228
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study 227
Using real-world healthcare data for pharmacovigilance signal detection-the experience of the EU-ADR project 227
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 227
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 225
Prescribing pattern of antipsychotic drugs during the years 1996–2010: a population-based database study in Europe with a focus on torsadogenic drugs 224
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 220
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project 217
Cardiovascular diseases burden in Italy, 1990–2017: the Global Burden of Disease Study 216
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey 215
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 213
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection 212
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases 212
Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial 212
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 211
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 209
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs 209
Immeasurable time bias nello studio dell'associazione tra utilizzo di bifosfonati orali e rischio di sanguinamento gastrointestinale. 207
Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: A validation study 206
Screening of older community-dwelling people at risk for death and hospitalization: The assistenza socio-sanitaria in italia project 206
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients 205
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' 204
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 203
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 202
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries 202
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries 202
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care 201
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? 201
Need and disparities in primary care management of patients with diabetes 201
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 200
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 200
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in rats 200
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks and public health considerations 200
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 199
Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor-induced inhibition of water intake in the rat 198
Use of azithromycin and risk of ventricular arrhythmia 197
Workshop: Indicatori di appropriatezza prescrittiva a sostegno delle politiche sanitarie. Relazione: Valutazione dell’impatto di programmi di minimizzazione del rischio: principi pratici e applicabilità degli indicatori di appropriatezza 197
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study 195
Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations 194
Suboptimal Gastroprotective Coverage of NSAID Use and the Risk of Upper Gastrointestinal Complications 194
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network 193
Harmonisation of the Event Identification Process in Eight European Healthcare Databases: the experience from the EU-ADR Project. 193
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 191
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease 187
Development and Validation of a Score for Adjusting Health Care Costs in General Practice 186
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study 186
Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods 185
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics 185
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study 184
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 183
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures 182
Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases 182
A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care 181
Pattern of antimicrobial drug prescribing and prescriptive behaviour for acute otitis media among physicians in Sicily 180
Chair sessione: storia della sanita’ pubblica II 180
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 179
Risk management and drug utilization research 177
Uso degli antidepressivi in Italia: un’analisi nel contesto della Medicina Generale 177
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study 176
Hypertension in dialysis patients 176
Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: A focus on elderly with dementia 175
Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance System 174
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective 174
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study 172
Drug utilization research and risk management 171
Antibiotic prescribing for dental conditions: A community-based study in southern Italy 170
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? 170
A cross-sectional survey on benzodiazepine use among older people in an Italian region 170
Assessing the risk of osteonecrosis of the jaw (onj) due to bisphosphonates (bp) therapy in the secondary prevention of osteoporotic fractures 170
Totale 24.105
Categoria #
all - tutte 184.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.067


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.188 125 290 273 165 116 176 128 130 111 76 119 479
2022/20233.413 673 917 287 176 165 628 37 130 220 56 74 50
2023/20243.459 64 116 115 118 556 836 659 94 530 82 76 213
2024/20259.562 509 1.508 450 403 820 226 302 246 1.348 1.180 936 1.634
2025/202620.897 2.285 1.925 1.531 1.955 1.594 913 2.445 1.043 1.614 1.500 2.299 1.793
2026/2027408 408 0 0 0 0 0 0 0 0 0 0 0
Totale 51.266